Notice of Summer Holidays
Notice of summer holidays From August 14, 2023 to August 18, 2023 We will start from August 21, 2023 We will
Notice of spring holidays
Notice of spring holidays From May 2, 2023 to May 7, 2023 We will start from May 8, 2023 We will be checking
Notice of winter holidays
Notice of winter holidays From Dec 28, 2022 to Jan 4, 2023 We will start from Jan 5, 2023 We will be checking
Notice of public holidays.
Notice of public holidays. From Apr 29, 2022(Friday) to May 8, 2022(Sunday) We will start from May 9, 2022(Mon
A new medium, iMediam for T, is now available.
Click to see details.
Chairman, Dr.Teruaki Sekine had a presentation on the 25th World Congress of Lymphology
The 25th World Congress of Lymphology has been held from September 7, 2015 till 11th in San Francisco . Approx
Completion of a technology transfer for the activated autologous lymphocyte therapy (Sekine method) to the Grand Zone Intl. Medical Group in Taiwan
Lymphotec Inc. has signed off a technology transfer agreement for the activated autologous lymphocyte therapy
September, 2014: LYMPHOTEC Inc. obtained the Exclusive Distribution Rights for Molecular Breast Imaging in APAC region from EVOWORDWIDE Inc.
September, 2014: LYMPHOTEC Inc. obtained the Exclusive Distribution Rights for Molecular Breast Imaging in APA
Announcement of our summer closing period
Our summer closing period is from Wednesday, August 12 through Sunday, August 16, 2015. We apologize for your
Lymphotec Inc. signed on a contract for a joint clinical study on activated autologous lymphocyte therapy with the 307th Hospital of Chinese People’s Liberation Army and Beijing Longbao Science & Technology Development Co., Ltd.
Outline of signing ceremony On Sunday, June 28, 2015, from 10 a.m., three institutions, Lymphotec Inc., the 30
Acquisition of ” Certificate for manufacturing of processed product of specific cells” specified in the laws related to the Act regarding Ensuring of Safety of Regenerative Medicine
We would like to announce that Lymphotec Inc. acquired “Certificate for manufacturing of processed produ
Dr. Hiroyuki Funamoto, the President and CEO of Lymphotec Inc., delivered lecture in the 14th Annual Meeting of Chinese Society of Cancer Biotherapy held in Beijing, China.
On May 17, Dr. Funamoto delivered lecture under the title of “Cancer treatment by activated autologous l
Conclusion of a technology transfer agreement for the activated autologous lymphocyte therapy (Sekine method) with the Grand Zone Intl. Medical Group in Taiwan
Lymphotec Inc. has concluded a technology transfer agreement for the activated autologous lymphocyte therapy (